{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:05:24Z","timestamp":1776099924867,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"abstract":"<jats:p>To investigate the clinical value of contrast-enhanced ultrasound in the prediction of hepatic encephalopathy (HE) in patients with hepatitis B cirrhosis after intrahepatic portal-systemic shunt via jugular vein. In this retrospective study, we collected data from 75 patients with hepatitis B, cirrhosis, and portal hypertension who underwent jugular intrahepatic portosystemic shunt from February 2019 to February 2022. The diagnostic instrument used was the TOSHIBA Aplio500 color Doppler ultrasound with contrast-enhanced ultrasound capabilities. The trial group comprised 20 patients with HE within 3 months postsurgery, while the control group (CG) included 55 patients without HE within the same postoperative period. All patients underwent various examinations before and within 48 hours after surgery, including observation of liver and spleen size and stent position, as well as assessment of blood flow direction in portal and hepatic veins. Subsequently, contrast-enhanced ultrasound was employed to examine and observe perfusion changes of contrast agents in hepatic veins, hepatic arteries, and portal veins (PV). Changes in PV pressure gradient, intrahepatic, and stent blood flow perfusion (BFP) were explored in both postoperative trials and CGs. The trial group exhibited higher BFP volume, PV pressure gradient difference, and percentage decrease compared to the CG. A weak positive correlation was observed between blood flow within the liver stent and PV pressure gradient difference, as well as the percentage decrease in PV pressure gradient. The correlation coefficient between blood flowing perfusion volume within the stent and the difference in PV pressure gradient was <jats:italic toggle=\"yes\">R<\/jats:italic>\u2005=\u20050.415 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.000). The correlating coefficient between BFP amount within the stent and the percentage decrease in PV pressure gradient was <jats:italic toggle=\"yes\">R<\/jats:italic>\u2005=\u20050.261 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.027). The area under the receiver operating characteristic curve for stent perfusion volume, difference in PV pressure gradient, and percentage decrease in PV pressure gradient was 0.691, 0.759, and 0.742, respectively. An increase in PV pressure gradient accelerates blood flow within the stent, predisposing to HE. Changes in hepatic BFP following transjugular intrahepatic portosystemic shunt can effectively predict the occurrence of HE, demonstrating significant clinical relevance.<\/jats:p>","DOI":"10.1097\/md.0000000000037899","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T18:01:58Z","timestamp":1714154518000},"page":"e37899","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation and clinical significance of contrast-enhanced ultrasound on changes in liver blood flow perfusion after TIPS surgery"],"prefix":"10.1097","volume":"103","author":[{"given":"Meirong","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Wuxi Fifth People\u2019s Hospital, Wuxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Wuxi Fifth People\u2019s Hospital, Wuxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Interventional, Wuxi Fifth People\u2018s Hospital, Wuxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueping","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Wuxi Fifth People\u2019s Hospital, Wuxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Wuxi Fifth People\u2019s Hospital, Wuxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3708-7131","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Interventional, Wuxi Fifth People\u2018s Hospital, Wuxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension.","volume":"20","author":"Boike","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M20-0202","article-title":"The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled trial.","volume":"174","author":"Bureau","year":"2021","journal-title":"Ann Intern Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.cgh.2019.03.042","article-title":"Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival.","volume":"17","author":"Trebicka","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hep.30934","article-title":"A prospective study identifying predictive factors of cardiac decompensation after transjugular intrahepatic portosystemic shunt: the toulouse algorithm.","volume":"70","author":"Billey","year":"2019","journal-title":"Hepatology"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/apt.15797","article-title":"Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding.","volume":"52","author":"Dunne","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/liv.15060","article-title":"The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.","volume":"41","author":"Gioia","year":"2021","journal-title":"Liver Int"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S2468-1253(22)00087-5","article-title":"Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial.","volume":"7","author":"Lv","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/hep.31913","article-title":"Combination of model for end-stage liver disease and lactate predicts death in patients treated with salvage transjugular intrahepatic portosystemic shunt for refractory variceal bleeding.","volume":"74","author":"Walter","year":"2021","journal-title":"Hepatology"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis.","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jvir.2019.01.005","article-title":"Muscle gain after transjugular intrahepatic portosystemic shunt creation: time course and prognostic implications for survival in cirrhosis.","volume":"30","author":"Jahangiri","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/2050640620952637","article-title":"Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.","volume":"9","author":"Horhat","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jvir.2018.10.003","article-title":"Technical feasibility and clinical effectiveness of transjugular intrahepatic portosystemic shunt creation in pediatric and adolescent patients.","volume":"30","author":"Bertino","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.14309\/ajg.0000000000001194","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis: a prospective observational study.","volume":"116","author":"Lv","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jvir.2020.10.009","article-title":"Combined transjugular intrahepatic portosystemic shunt plus variceal obliteration versus transjugular intrahepatic portosystemic shunt alone for the management of gastric varices: comparative single-center clinical outcomes.","volume":"32","author":"Shah","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/MEG.0000000000001628","article-title":"Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals.","volume":"32","author":"Steib","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jvir.2018.10.015","article-title":"Proton pump inhibitor use is associated with an increased frequency of new or worsening hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.","volume":"30","author":"Lewis","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1111\/jgh.15543","article-title":"Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt.","volume":"36","author":"Yang","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jgh.15714","article-title":"Does preemptive transjugular intrahepatic portosystemic shunt improve survival after acute variceal bleeding? Systematic review, meta-analysis, and trial sequential analysis of randomized trials.","volume":"37","author":"Hussain","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/hep4.1308","article-title":"Left ventricular longitudinal contractility predicts acute-on-chronic liver failure development and mortality after transjugular intrahepatic portosystemic shunt.","volume":"3","author":"Jansen","year":"2019","journal-title":"Hepatol Commun"},{"key":"R20-20250503","first-page":"72","article-title":"Study of portal venous pressure gradient to predict high-hepatic encephalopathy-risk population post TIPS","volume":"29","author":"Zhang","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3748\/wjg.v29.i15.2336","article-title":"Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.","volume":"29","author":"Luo","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jhep.2013.06.014","article-title":"TIPS: 25 years later.","volume":"59","author":"R\u00f6ssle","year":"2013","journal-title":"J Hepatol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.diii.2020.11.004","article-title":"Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: a systematic review and meta-analysis.","volume":"102","author":"Huang","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jvir.2018.10.006","article-title":"Psoas muscle density in combination with model for end-stage liver disease score can improve survival predictability in transjugular intrahepatic portosystemic shunts.","volume":"30","author":"Shoreibah","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/hep4.2062","article-title":"Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt.","volume":"6","author":"Meucci","year":"2022","journal-title":"Hepatol Commun"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/MEG.0000000000001349","article-title":"Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.","volume":"31","author":"Leng","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:40:09Z","timestamp":1746319209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":26,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037899","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}